An immunocompetent, permissive small-animal model would be valuable for the study of human immunodeficiency virus (HIV)-1 pathogenesis and for the testing of drug and vaccine candidates. However, the development of such a model has been hampered by the inability of primary rodent cells to efficiently support several steps of the HIV-1 replication cycle. Although transgenesis of the HIV receptor complex and human Cyclin T1 have been beneficial, additional late-phase blocks prevent robust replication of HIV-1 in rodents and limit the range of in vivo applications. In this study, we explored the HIV-1 susceptibility of rabbit primary T-cells and macrophages. Envelope-specific and co-receptor-dependent entry of HIV-1 was achieved by expressing human CD4 and CCR5. A block at HIV-1 DNA synthesis, likely mediated by TRIM5, was overcome by limited changes to the HIV-1 gag gene. In contrast to mice and rats, primary cells from rabbits supported the functions of the regulatory viral proteins Tat and Rev, Gag processing, and the release of HIV-1 particles at levels comparable to human cells. While HIV-1 produced by rabbit T-cells was highly infectious, a macrophage-specific infectivity defect became manifest by a complex pattern of mutations in the viral genome, only part of which were deamination-dependent. These results demonstrate a considerable natural HIV-1 permissivity of the rabbit species and suggest that receptor complex transgenesis combined with modifications in gag and possibly vif of HIV-1 to evade species-specific restriction factors might render lagomorphs fully permissive to infection by this pathogenic human lentivirus.
INTRODUCTION 1
New infectable small-animal models of HIV-1 infection are needed to complement existing 2 models for the study of viral pathogenesis, the in vivo evaluation of new antiviral compounds, 3 and the testing of vaccine candidates. While existing animal models have made significant 4 contributions, they have serious limitations. For example, the rhesus macaque model was 5 instrumental for elucidating lentiviral pathogenesis and for evaluating fundamental concepts in 6 vaccine development and drug intervention (38, 56, 70, 73) . However, these non-human primate 7 studies are limited by ethical concerns, small animal group sizes, and high cost. In addition, the 8 animals can only be infected with simian immunodeficiency virus (SIV) or SIV/HIV chimeric 9
viruses. 10
Over the past few years, considerable progress has been made in the development of 11 xenotransplant models. Some of these allow transmission of HIV via the vaginal or rectal mucosa 12 and display high-level viremia and CD4 T-cell depletion (4, 21, 65) . Recently, a feasible antiviral 13 gene therapy approach was reported (55). Unfortunately, these models are technically challenging 14 and time-consuming and not amenable for wide-spread use. Moreover, HIV-1-infected, 15 xenotransplanted mice mount low or dysfunctional adaptive immune responses to HIV infection 16 (5, 15) , limiting studies of natural immune control and vaccine testing. 17
An alternative approach for developing HIV animal models in native rodents has been to 18 identify and then surmount species-specific barriers that HIV encounters during its replication. 19
The ultimate goal is to use this knowledge to generate immunocompetent transgenic small 20 animals that are fully permissive for HIV replication. We and others have characterized such 21 barriers in the early phase of HIV replication in mouse and rat cells (8, 32, 43, 50, 51, 72) and 22 have successfully overcome them by transgenic expression of appropriate human cofactors (CD4, 23 CCR5, CXCR4 and Cyclin T1) in laboratory rodents (16, 42, 51, 76) . to 84-fold greater than those of the parental HIV-1 vector ( Fig. 2A) . This confirmed that the viral 4 target of the post-entry restriction of HIV-1 in rabbit cells is the capsid protein (62). Notably, this 5 chimeric vector achieved higher infection levels in SIRC than in HeLa cells (8-fold, Fig. 2B ). 6
The rabbit-specific restriction mapped to the level of reverse transcription. While the entry levels 7
were similar for both vectors in SIRC cells (Fig. 2C , Entry), HIV-1 cDNA synthesis was severely 8 blocked for the BlaM-Vpr HIV-1 vector but not the BlaM-Vpr HIV-1 (H/SCA) chimera (Fig. 2C , 9 reverse transcription). As a consequence of the lower HIV-1 cDNA synthesis, levels of HIV-1 10 2-LTR circles (Fig. 2C , nuclear import), used as a surrogate marker for nuclear import of the 11 preintegration complex, and viral gene expression (Fig. 2C , gene expression) were reduced to 12 similar degrees. Importantly, the HIV-1 (H/SCA) vector also displayed much greater infectivity 13 (up to 195-fold) in rabbit macrophages than the HIV-1 vector (Fig. 3A) . We also confirmed 14 experimentally that, in this primary cell type, an early post-entry event preceding or at nuclear 15 import was affected ( determine if co-expression of hCD4 and hCCR5 could overcome the entry block in rabbit cells, 22
we first generated a SIRC-derived clone that stably expressed the human receptor complex. High 23 co-expression of both human receptors on the surface of sorted and subcloned SIRC 24 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from hCD4/hCCR5 cells was confirmed by flow cytometry (Fig. 4A) . Importantly, in these cells, 1 infections by HIV-1 (H/SCA) pseudotypes depended on the viral envelope and the co-receptor 2 (Fig. 4B) . Specifically, SIRC hCD4/hCCR5 cells were susceptible to infection by R5 Env (strain 3 JR-FL) pseudotypes, but non-permissive for X4 Env (strain NL4-3) pseudotypes of HIV-1 4 (H/SCA) (Fig. 4B ). As expected, both parental SIRC and SIRC hCD4/hCCR5 cells were 5 permissive for VSV-G pseudotypes of the HIV-1 (H/SCA) vector, but not of the TRIM5-6 restricted parental HIV-1 vector. The apparently lower degree of restriction of SIRC 7 hCD4/hCCR5 cells compared to the parental cells to infection by VSV-G HIV-1 wt pseudotypes 8 is likely a clonal phenomenon unrelated to expression of the HIV receptor complex. As additional 9 controls of specificity, SIRC hCD4/hCCR5 cells were pretreated with the CCR5 antagonist 10 maraviroc or the fusion inhibitor T20 which resulted in a reduction of infection levels of the R5 11 Env HIV-1 (H/SCA) vector by 90% or 99.9%, respectively, while the CXCR4 antagonist 12 AMD3100 had no effect (Fig. 4B ). The incomplete inhibition by maraviroc is probably due to the 13 high expression levels of the coreceptor on SIRC hCD4/hCCR5 cells (Fig. 4A ) and the 14 requirement for only very low cell surface concentrations of the coreceptor for HIV-1 entry, as 15 reported previously (76) . 16
Seeking to extend these entry analyses to primary cells, we identified Turbofect as fairly well-17 suited for the delivery of plasmid DNA into rabbit macrophages (data not shown). Co-18 transfection of expression plasmids for hCD4 and hCCR5 into spleen-derived rabbit 19 macrophages resulted in a significant population of human receptor-positive cells (Fig. 4C) . 20
Importantly, challenge of these cells with the R5 Env pseudotyped HIV-1 (H/SCA) GFP vector, 21
but not with the HIV-1 GFP counterpart, allowed for infection and reporter gene expression, as 22 visualized by microscopy ( Fig. 4D ) and quantified by flow cytometry (Fig. 4E ). Macrophage 23 cultures, which were either transfected with an empty plasmid or on which expression of hCD4 24 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from and hCCR5 was very low or absent, or, where only one of them was expressed, remained 1 resistant to infection with the JR-FL Env HIV-1 (H/SCA) GFP vector (data not shown). 2
Collectively, these results demonstrate that co-expression of hCD4 and hCCR5 on rabbit cells, 3 including primary macrophages, is functional and confers co-receptor-specific virus entry, 4 providing a strong basis for HIV receptor complex transgenesis in this species. 5 HIV-1 LTR transactivation is species-and cell type-specific and occurs efficiently in 6 primary rabbit cells. We (32, 43, 51) and others (1, 48, 72) described a quantitative impairment 7 of Tat-dependent HIV-1 LTR transactivation in native rat and mouse cells, which is primarily due 8 to an inefficient TAR-Tat-Cyclin T1 interaction. This species-specific limitation was mapped to a 9 single amino acid in Cyclin T1 (tyrosine-261 in rodents; cysteine-261 in human) (10, 26) . 10 Rabbit Cyclin T1 is 91% identical at the amino acid level to human Cyclin T1 and, notably, 11
shares cysteine-261 with the human ortholog (Fig. 5A) . It was previously suggested that Tat and 12
Rev functions are at least partly preserved in SIRC cells (63). To assess HIV LTR-driven 13 transcription in primary rabbit T-cells, minimal reporter plasmids, consisting of the complete, 14 PCR-amplified LTR and Gag-leader sequences from either HIV-1 NL4-3 or HIV-2 ROD-A , driving the 15 expression of GFP (pHIV LTR GFP) (51), and Tat expression constructs were co-transfected. 16
The basal, Tat-independent transcription was low and comparable for T-cells from all four 17 species (data not shown). Importantly, co-expression of Tat increased levels of HIV LTR-driven 18 gene expression in primary T-cells from rabbits ~10-fold (for HIV-1 (Fig. 5B ) and data not 19 shown for HIV-2), which was comparable to the enhancement in human T-cells (sevenfold for 20 HIV-1; Fig. 5B , and ninefold for HIV-2; data not shown). In contrast, T-cells from both rodents 21 showed a minor, 1.2-to 2-fold Tat-mediated induction, in agreement with previous studies 22 conducted in the absence of hCyclin T1 co-expression (8, 43, 50) . 23
To assess HIV transcriptional activity in macrophages from all of these species, primary 24 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from cultures were infected with the near full-length HIV-1 NL4-3 GFP virus pseudotyped with VSV-G. 1
Here, the 5' LTR drives GFP expression from the nef locus. GFP expression from integrated 2 proviruses under single cell infection conditions is a quantitative surrogate of early, LTR-driven 3 gene expression. Viral titers were chosen such that macrophages from all four species had 4 relatively low numbers of infected, GFP-positive cells (0.4 to 7.8%). In contrast to T-cells, 5 macrophages from mice, rats, rabbits and humans supported LTR-driven gene expression from 6 the nef locus to similar levels ( Fig. 5C ), indicating a less stringent requirement for Cyclin T1 in 7 this cell type in rodents. Tat-dependence of HIV LTR transactivation in primary rabbit 8 macrophages was demonstrated using the HIV LTR GFP reporter/Tat co-transfection assay (Fig.  9   5D ). In summary, these results reveal pronounced species-and cell type-specific differences in 10 requirements for efficient HIV-1 transcription. Remarkably, primary T-cells and macrophages 11 from rabbits support Tat-dependent HIV LTR transactivation at levels similar to those from 12
humans. 13
Rabbit cells support robust Rev/CRM1-dependent HIV-1 gene expression. In rodent 14 cells, the expression of late HIV gene products is low and represents a major post-transcriptional 15 barrier. Inefficient Rev function has been suggested to limit the nuclear export of Rev-responsive 16 element (RRE)-containing unspliced and singly-spliced HIV mRNAs or to result in over-splicing 17 of viral RNAs (8, 19, 50, 74, 77) . 18
To simultaneously assess HIV Tat and Rev function, we used a reporter plasmid that contains 19 HIV-1 LTRs, the 5′ section of gag containing inhibitory sequences (INS), and the RRE to direct 20 Tat (Fig. 6A) . As controls for specificity, the Tat-/Rev-dependent reporter gene 5 expression in rabbit and human cells was markedly reduced by LMB treatment (23), co-6 expression of a dominant-negative form of nucleoporin 214/CAN (∆CAN/Nup214) (12), or 7 saturating levels of short NLS/NES sequences (22, 39) (Fig. 6B) ; all of these have been reported 8 to interfere with CRM1-dependent nuclear export of viral RNAs. 9
We next extended this reporter-based strategy to primary T-cells. In agreement with the 10 findings in cell lines, Tat/Rev co-expression resulted in 102-and 232-fold enhancements of RFP 11 expression in transfected T-cells from humans and rabbits, respectively (Fig. 6C ), while T-cells 12 from rats and mice responded poorly. Finally, we used a second, independent experimental 13 approach to assess the functionality of the viral Rev protein in primary T-cells. We quantified the 14 expression of a late, Rev-dependent gene product (MA.GFP) (52) relative to an early, Rev-15 independent gene product (Nef) in a near full-length proviral context. T-cells from both rodents 16 showed strong Rev-independent GFP reporter expression from the nef locus, whereas Rev-17 dependent MA.GFP expression was fairly weak, resulting in a "late-to-early" ratio of below 0.3 18 (Fig. 6D) . Expectedly, transgenic expression of hCyclin T1 in rat T-cells (51) enhanced GFP 19 expression from both proviruses, but did not significantly affect this ratio (Fig. 6D) . In contrast to 20 the rodent species, T-cells from rabbits and humans displayed a stronger expression of MA.GFP, 21 and GFP expression levels from both proviral loci were similar in these species (Fig. 6D) . These 22 results demonstrate that the two major barriers to HIV-1 replication in rodents, at the level of Tat provirus-transfected rabbit T-cells contained abundant levels of early (Nef) and late (Gag, Vpu) 10 HIV-1 proteins (Fig. 7A) . At comparable transfection efficiencies (Fig. 7B) , the cell-associated 11 expression of these viral proteins in rabbit T-cells was comparable or higher than in human 12 reference T-cells. Notably, processing of the p55Gag precursor to p24CA, which is generally 13 believed to be impaired in rodent cells (8, 43, 50) , was efficient in the rabbit species (Fig. 7A) . 14 Furthermore, the number of HIV virions released into the supernatant was comparable or higher 15 in T-cells from rabbits than from humans (Fig. 7C ). Under these experimental conditions, the 16 average inter-species transfection efficiencies, despite considerable inter-individual variability, 17 were comparable (Fig. 7B) . We can, however, not exclude that variable amounts of proviral DNA 18 delivered per cell contributed to the somewhat higher levels of viral gene products in cell lysates 19 (Fig. 7A ) and released virions in T-cells (Fig. 7C ) from rabbits compared to humans. 20
Finally, the infectivity of these transfection-derived HIV-1 particles was quantified in a 21 standard TZM-bl reporter assay (Fig. 7E) (40) . When infectivity values were normalized to the 22 p24CA concentration of released virions, HIV-1 produced by primary T-cells from rabbits and 23 humans was equally infectious (Fig. 7D) . Thus, the late phase of HIV-1 replication in primary 24
on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from rabbit T-cells is efficient, revealing a degree of intrinsic susceptibility of lagomorph T-cells to 1 this human lentivirus that has not been reported for any other non-human species. 2
Rabbit macrophages efficiently release HIV-1 virions, but their infectivity is low. Next 3 we examined the ability of primary rabbit macrophages to support the late phase of the HIV-1 4 replication cycle. Cells were transfected with proviral DNA. The transfection efficiency, assessed 5 by parallel transfections with a near full-length proviral HIV-1 GFP reporter, ranged from 4 to 6 11% (data not shown). Despite this rather low transfection efficiency, western blot analysis of 7 macrophage lysates showed considerable expression and processing of Gag (Fig. 8A ). Since 8 human macrophages cannot be transfected efficiently with proviral DNA, VSV-G HIV-1 NL4-3-9 infected cells served as references. Importantly, rabbit macrophage supernatants contained 10 significant amounts of HIV-1 with virion-associated p24CA concentrations up to 144 ng per ml 11 (mean: 26 ng p24CA per ml); Fig. 8B ). HIV-1 release, expressed as the percentage of total 12 p24CA (in cells and supernatant) that was secreted as virion-associated p24CA, was comparable 13 for the HIV-1 provirus-transfected rabbit macrophages and VSV-G HIV-1-infected human 14 macrophages ( Fig. 8C ), providing no evidence for a species-specific defect for wild-type HIV-1 15 at egress. 16
Unexpectedly, the infectivity of HIV-1 particles derived from rabbit macrophages was 17 markedly less than those derived from human macrophages (26-fold; Fig. 8D , E). Thus, rabbit 18 macrophages apparently support all late steps of HIV-1 replication, yet induce an infectivity 19 defect in released particles. 20
Rabbit macrophage-derived HIV-1 carries a complex pattern of mutations. We 21 hypothesized that the infectivity defect of HIV-1 released from rabbit macrophages might be due 22 to the mutating activity of rabbit members of the APOBEC family. To characterize this, viral 23
DNAs were recovered from TZM-bl cells infected with HIV-1 NL4-3 produced by either 24 macrophages or T-cells from rabbits, and a nef/3'-LTR fragment was then PCR-amplified, 1 cloned, and individual sequences determined, in principle as reported (11). None of the sequences 2 amplified from T-cell-derived virus carried mutations (Fig. 9A ), in line with the high infectivity 3 of T-cell-derived HIV-1 (Fig. 7D) . In contrast, macrophage-derived HIV-1 cDNAs displayed 4 multiple mutations in 51 out of 54 clones analyzed and at an overall frequency of 0.74% (Fig.  5 9A, C). These clones were derived from 3 independent infection assays and clone analyses on 6 TZM-bl cells with HIV-1 virions derived from 4 different rabbit donor macrophages. Virtually all 7 clones carried 6 different types of nucleotide changes (G→A, C→T, A→C, T→C, T→G, G→T) 8 at the identical nucleotide positions (e.g. boxed nucleotide changes in Fig. 9A ). Besides this 9 major pattern of mutations additional single nucleotide changes were found in individual clones 10 at multiple sites in the amplified region, resulting in a total of 8 different clones. The G→A and 11 C→T mutations were detected at frequencies of 0.9 to 1.5%, respectively, consistent with both 12 DNA editing and RNA editing by a cellular deaminase (11, 37). Remarkably, however, 13 considerable levels of other, deamination-independent HIV-1 cDNA mutations were also noted 14 (A→C, T→C, T→G, G→T) that all occurred at frequencies of ~1% ( Figure 9A , C). The 15 occurrence of preferential sites of mutations was analyzed (Fig. 9B ). The G→A, C→T and T→C 16 changes showed no apparent consensus pattern. For T→G and A→C changes two trinucleotide 17 sequences (up-and downstream of the affected T and A, respectively) were noted. For G→T, 18 TCTG*GCT was the only sequence context for this mutation ( In the present study, we quantitatively characterized the ability of primary T-cells and 2 macrophages from rabbits to support critical steps in the HIV-1 replication cycle. We found that 3 primary target cells in rabbits are permissive to HIV-1 infection and support the majority of 4 replication steps as well as human cells. Of the three replication barriers HIV-1 encounters in 5 lagomorphs, two can be readily overcome: expression of the HIV receptor complex and limited 6 modifications in the N-terminal part of the HIV-1 capsid surmount blocks at entry and reverse 7 transcription, respectively. In addition, we identified a virion infectivity defect in macrophages 8 that is absent in T-cells and that poses the final cellular barrier to full HIV-1 permissivity in this 9
species. 10
The HIV-1 entry block is due to the general inability of CD4 and/or major chemokine 11 receptors from non-human species to support virion binding and fusion (Fig. 10 ). Co-expression 12 of hCD4 and hCCR5 in SIRC cells and primary macrophages mediated envelope-specific and 13 co-receptor-dependent virion entry. These results agree with reports that surface expression of 14 the human binding receptor and one of the major chemokine co-receptors is sufficient to 15 overcome the entry block in cells from diverse primate and small-animal species (8, 16, 42, 43, 16 45, 49, 54, 76) . 17
In rabbit cells, unlike in mice and rats (32, 67, 76) , HIV-1 encounters a barrier early post-18 entry that leads to a strong block to viral DNA synthesis (7, 20, 36) ( Two major species-specific barriers to HIV-1 replication in rodents, one at the level of Tat-11 dependent LTR transactivation and the other affecting Rev-/RRE-dependent viral gene 12 expression (8, 43, 46, 50, 69) , are absent in the rabbit species (Fig. 10 ). This observation is 13 supported by multiple lines of experimental evidence with replication stage-specific reporter 14 assays and full-length infectious HIV-1. The absence of a transcriptional block can likely be 15 explained on the genomic level. The Tat-interacting protein Cyclin T1 is a key determinant for 16 the inability of rodent cells to support efficient LTR transactivation, and a tyrosine instead of a 17 cysteine at position-261 in the rodent orthologs plays a decisive role (10, 24, 26, 48) . This residue 18 is part of the Tat/TAR recognition motif of Cyclin T1 (2). Critically, rabbit Cyclin T1 shares 19 cysteine-261 with the human ortholog. In light of the strong Tat-dependent LTR activity in both 20 species, this finding underscores the functional importance of this amino acid in the cross-species 21 context. Interestingly, rodent macrophages seem to pose an exception in their degree of 22 dependence on Cyclin T1 for LTR activity: Irrespective of the amino acid residue at position 261, 23 macrophages from rodents, humans and rabbits supported comparable levels of provirus 5′-LTR-24 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from driven transactivation (this study and (32, 51)). This may relate to the ability of HIV to exploit a 1 distinct set of nuclear transcription factors and alternative mechanisms of transcriptional 2 regulation in macrophages compared to other cell types (for review (61, 71)). 3
Of great relevance for animal model development, the transcriptional impairment in primary 4 T-cells from rodents can be substantially ameliorated by hCyclin T1 transgenesis (51, 76). 5
However, a molecular understanding for the deficit in Rev function in rodent cells, or strategies 6 to overcome it, are entirely lacking (8, 18, 50, 69, 76) . The severe defect in the Rev-/CRM1-7 dependent export of unspliced and singly-spliced HIV-1 RNAs from the nucleus and oversplicing 8 of the viral RNA results in grossly reduced expression levels of structural proteins. Besides 9 transcription and nuclear export of RRE-containing viral RNAs, the processing of Gag, particle 10 assembly and release, as well as virion infectivity pose additional post-integration defects in 11 rodent cells. In primary mouse T-cells, the cumulative impact of these late-phase deficits results 12 in an up to 500-fold reduction in the yield of infectious virus after a single cycle (76), and this has 13 crippled efforts to advance a transgenic mouse model. 14 Importantly, we found a high natural HIV-1 permissivity in primary rabbit cells and, in 15 particular, an ability of T-cells to efficiently support the entire late phase of HIV-1 replication 16 (Fig. 10) . The number of infectious HIV-1 released after provirus transfection reflects the 17 cumulative efficiency of late-phase steps from transcription over assembly, to release and 18 maturation. At comparable transfection efficiencies, rabbit T-cells released comparable or higher 19 levels of infectious virions compared to their human counterparts. We predict that an 20 N-terminally CA-modified HIV-1, that can circumvent the post-entry restriction, could spread in 21 primary rabbit T-cells carrying the HIV receptor complex. However, neither the hCCR5 nor 22 hCXCR4 co-receptor could be transiently expressed in these cells (data not shown). Therefore, 23 transgenic expression of the HIV receptor complex will be required to probe the full replication 24 
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